Table 2.
Sample characteristics.
| Sample characteristics | Mean (SD) | Range |
|---|---|---|
| Age (in years) | 43.53 (12.25) | 20–62 |
| Duration of smell/taste impairment prior to receiving CVFLA (in days) | 236.66 (234.91) | 28–817 |
| Mental health and well-being | ||
| Depression (DASS-21) | 9.13 (7.97) | 0–30 |
| Anxiety (DASS-21) | 10.80 (10.25) | 0–32 |
| Stress (DASS-21) | 13.33 (9.96) | 0–30 |
| Well-being Index 9 (WHO-5) | 13.00 (4.31) | 7–21 |
| Introspective awareness | ||
| Noticing (MAIA-2) | 3.75 (0.86) | 1.75–5 |
| Not-distracting ((MAIA-2) | 2.14 (1.39) | 1.60–4.85 |
| Not-worrying (MAIA-2) | 2.87 (0.68) | 0.60–3.80 |
| Attention-regulation (MAIA-2) | 3.15 (1.24) | 1.29–5 |
| Emotional- awareness (MAIA-2) | 4.03 (0.81) | 2.20–5 |
| Self-regulation (MAIA-2) | 3.38 (1.08) | 1.50–5 |
| Body-listening (MAIA-2) | 2.75 (1.32) | 1–5 |
| Trusting (MAIA-2) | 3.53 (1.23) | 1–5 |
DASS-21, Depression Anxiety Stress Scale (DASS-21; Lovibond and Lovibond, 1995); WHO-5, World Health Organization Well-being Index (WHO-5; Bech et al., 1996). MAIA-2: Multidimensional Awareness of Introspective Awareness-2 (MAIA-2; Mehling et al., 2018)